-transparent.png){kind=logo}
Heart valve prostheses carry a risk for thrombosis and require an antithrombotic strategy to prevent stroke, systemic embolism, and prosthetic valve thrombosis. Contemporary randomized trials to guide the clinician on the optimal anticoagulant treatment are scarce, and the validity of the historical data for current recommendations can be questioned in view of the changes in valve prostheses, the patient population, and antithrombotic therapies. This limited evidence from clinical trials translates into divergent recommendations from the different scientific societies on the optimal intensity of oral anticoagulation and on the indication for antiplatelet therapy. The availability of new antithrombotic agents and the unclear thrombotic risk of the currently used prostheses underscore the need to redefine antithrombotic treatment in patients with heart valve prostheses.
Hadewich Hermans, and
Thomas Vanassche, and
Paul Herijgers, and
Bart Meuris, and
Marie-Christine Herregods, and
Frans Van de Werf, and
Peter Verhamme
November 1996,
Archives des maladies du coeur et des vaisseaux,
Hadewich Hermans, and
Thomas Vanassche, and
Paul Herijgers, and
Bart Meuris, and
Marie-Christine Herregods, and
Frans Van de Werf, and
Peter Verhamme
April 1975,
Minerva medica,
Hadewich Hermans, and
Thomas Vanassche, and
Paul Herijgers, and
Bart Meuris, and
Marie-Christine Herregods, and
Frans Van de Werf, and
Peter Verhamme
May 2007,
Expert review of cardiovascular therapy,
Hadewich Hermans, and
Thomas Vanassche, and
Paul Herijgers, and
Bart Meuris, and
Marie-Christine Herregods, and
Frans Van de Werf, and
Peter Verhamme
December 1991,
Cardiologia (Rome, Italy),
Hadewich Hermans, and
Thomas Vanassche, and
Paul Herijgers, and
Bart Meuris, and
Marie-Christine Herregods, and
Frans Van de Werf, and
Peter Verhamme
November 1979,
Akusherstvo i ginekologiia,
Hadewich Hermans, and
Thomas Vanassche, and
Paul Herijgers, and
Bart Meuris, and
Marie-Christine Herregods, and
Frans Van de Werf, and
Peter Verhamme
January 1977,
Bollettino della Societa italiana di cardiologia,
Hadewich Hermans, and
Thomas Vanassche, and
Paul Herijgers, and
Bart Meuris, and
Marie-Christine Herregods, and
Frans Van de Werf, and
Peter Verhamme
July 1997,
Thrombosis and haemostasis,
Hadewich Hermans, and
Thomas Vanassche, and
Paul Herijgers, and
Bart Meuris, and
Marie-Christine Herregods, and
Frans Van de Werf, and
Peter Verhamme
February 1994,
American heart journal,
Hadewich Hermans, and
Thomas Vanassche, and
Paul Herijgers, and
Bart Meuris, and
Marie-Christine Herregods, and
Frans Van de Werf, and
Peter Verhamme
May 2004,
The Journal of heart valve disease,
Hadewich Hermans, and
Thomas Vanassche, and
Paul Herijgers, and
Bart Meuris, and
Marie-Christine Herregods, and
Frans Van de Werf, and
Peter Verhamme
January 1986,
Zeitschrift fur Kardiologie,
